Search
People
Camilo VargasSenior Solutions Development Lead, Geospatial Health and Development Data Engine
People
Amanda ZaffinoAmanda is a Certified Child Life Specialist and has a Bachelor of Science in Psychology and Master of Arts in Education with an emphasis on Child Life in Hospitals and Early Childhood Education.
Research
Narrowband UVB phototherapy for clinically isolated syndrome: A trial to deliver the benefits of vitamin D and other UVB-induced moleculesThe PhoCIS trial provides a fresh approach to re-defining the reported associations of 25(OH)D levels with multiple sclerosis development and progression
Research
Introduction to the themed issue The health benefits of UV radiation exposure through Vitamin D production or non-Vitamin D pathwaysThe health benefits of UV radiation exposure through Vitamin D production or non-Vitamin D pathways
Research
Early life nutrition and the opportunity to influence long-term health: an Australasian perspectiveThere is significant data to support the hypothesis that early life nutrition in the fetus, infant and young child can have profound effects on long-term health
Research
Biofilm forming potential and antimicrobial susceptibility of newly emerged Western Australian Bordetella pertussis clinical isolatesIsobaric tags for relative and absolute quantitation (iTRAQ)-based proteomic analysis revealed significant differences in protein expression in B. pertussis biofilms
Research
Effectiveness and experiences of families and support workers participating in peer-led parenting support programs delivered as home visiting programsPositive impact of peer-led home visiting parent support programs, incorporating a framework of partnership between parents and home visitors
Research
Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of DiabetesThe IHSG recommends that the frequency of detection of a glucose concentration <3.0mmol/L, to be included in clinical trial reports of glucose lowering drugs.